 Multiple center, double-blind, randomized, placebo-controlled study to see if it is safe to give ACHN-490 Injection for 5 consecutive days, to measure plasma pharmacokinetics, and to determine lung penetration of ACHN-490 measured in ELF-epithelial lining fluidafter a single dose of ACHN-490 Injection in healthy volunteers. 